Gilead Sciences EPS Basic from Discontinued Operations (Quarterly) Analysis

Gilead Sciences, Inc. (GILD)

122.55 -1.52 (-1.23%) USD | NASDAQ | Jan 15, 12:34

View EPS Basic from Discontinued Operations (Quarterly) for GILD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Discontinued Operations (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Discontinued Operations (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Discontinued Operations (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Johnson & Johnson	Upgrade
Eli Lilly & Co.	--
Merck & Co., Inc.	--
Regeneron Pharmaceuticals, Inc.	--